1-19 of 19
Keywords: platelet aggregation
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Clin Sci (Lond) (2004) 106 (1): 27–34.
Published: 01 January 2004
... contribute to platelet aggregation and to maintain the response to diuretics in advanced cirrhosis. In the present study, we tested the effects of a dietary supplementation for 8 weeks with a triacylglycerol (triglyceride) enriched in AA (ARASCO®; 4 g/day) or oleic acid (OA) on plasma and membrane fatty acid...
Articles
Articles
Clin Sci (Lond) (1999) 97 (3): 345–353.
Published: 30 July 1999
... study. After a 30 min infusion of ⌊-NMMA or placebo, NO inhalation (30 p.p.m) was added during the remaining 30 min of infusion, on both occasions. Measurements included filtragometry ex vivo (reflecting platelet aggregability), flow-cytometric evaluation of platelets in whole blood (fibrinogen binding...
Articles
Clin Sci (Lond) (1996) 91 (2): 225–231.
Published: 01 August 1996
... if inhaled nitric oxide influences platelet function in vivo in healthy subjects. 2. Platelet aggregability (filtragometry ex vivo , which reflects aggregability in vivo ), bleeding time and platelet secretion products and cGMP in plasma were studied during inhalation of two different doses of nitric oxide...
Articles
Articles
Clin Sci (Lond) (1995) 88 (3): 277–283.
Published: 01 March 1995
... to 10 −6 mol/l had no effect on platelet aggregation or intracellular free calcium concentration but inhibited in a dose-dependent manner aggregation induced by 0.05 unit/ml thrombin (p D 2 for inhibition by endothelin = 8.1 ± 0.12). 3. Endothelin-1 at 10 −9 mol/l significantly decreased ( P <0.01...
Articles
Articles
Articles
Articles
Articles
Clin Sci (Lond) (1991) 81 (5): 691–694.
Published: 01 November 1991
... (0.05–0.1 μmol/l) was used to reduce the filter occlusion time ( t A , a measure of platelet aggregate formation in blood) from approximately 600 s to 71–101 s in the absence of other agents. 3. Adenosine was infused into the tubing system of the filtragometer, yielding a contact time of >25 s...
Articles
Clin Sci (Lond) (1990) 78 (1): 113–116.
Published: 01 January 1990
... on the response of platelets to sodium arachidonate. 4. These results indicate that intraplatelet arginine vasopressin is released during aggregation and suggest that a local release of arginine vasopressin could occur after complete platelet aggregation in vivo. 24 7 1989 14 8 1989 © 1990...
Articles
Clin Sci (Lond) (1989) 77 (1): 99–103.
Published: 01 July 1989
...R. K. McCulloch; J. Summers; R. Vandongen; I. L. Rouse 1. At present it is unclear whether platelet-activating-factor (PAF)-induced aggregation is mediated by thromboxane. To obtain further information about this event we have compared the affects of aspirin on platelet aggregation and secretion...
Articles
Clin Sci (Lond) (1987) 73 (5): 507–513.
Published: 01 November 1987
... 2 1987 18 5 1987 © 1970 The Biochemical Society and the Medical Research Society 1970 adenosine 3′:5′-cyclic monophosphate α 2 -adrenoceptor ageing platelet aggregation ...
Articles
Articles
Articles
Clin Sci (Lond) (1982) 63 (s8): 391s–393s.
Published: 01 October 1982
... predisposition. 2. The activity of platelet aggregation was significantly greater in men with a genetic predisposition to essential hypertension. 3. Platelet aggregation was activated directly or indirectly by an increased sodium intake. 4. This activation by an increased sodium intake was more pronounced in men...
Articles
Clin Sci (Lond) (1982) 62 (2): 177–181.
Published: 01 February 1982
... 1981 30 9 1981 © 1982 The Biochemical Society and the Medical Research Society 1982 6-keto-prostaglandin E 1 6-ketoprostaglandin F 1α plasma platelet aggregation prostacyclin CIfnicalScience (1982) 62,177-181 177 Protection of prostacyclin-like activity in human plasma - a non...
Articles
Clin Sci (Lond) (1982) 62 (2): 239–242.
Published: 01 February 1982
...M. Porta; E. Cagliero; E. M. Kohner 1. Abnormal plasma levels of von Willebrand factor are accompanied by abnormal platelet function in some disease states. 2. Platelet retention in glass bead columns, platelet aggregation in vitro , β-thromboglobulin and 6-oxo-prostaglandin F 1α were monitored...